bioresearch-filters-purificationFeaturedArticles

1. Don't Blame The Molecule; You May Be The Problem 5/6/2024

   Ali Pashazadeh has been a healthcare investment banker for 20 years, surgeon for 30, and biotech CEO. Today he leads Treehill Partners. “I can explain our logic in two minutes,” he says of his approach to developing drugs, and targeting diseases.

2. Directed Energy Weapons: From The Mirrors Of Archimedes To Iron Beam 6/27/2024

   The U.S., China, France, Germany, the U.K., Russia, India, Israel, and Pakistan are all working to develop military-grade directed energy weapons. While mostly in the developmental stage, they are fast becoming the practical, high-performance military option of tomorrow.

3. Are Bioprocess Equipment Standards A One-Sided Conversation? 7/31/2024

   Half of respondents to a recent survey of biopharmaceutical companies said the greatest challenge in further growing industry acceptance of single-use technology—which now comprises an eye-popping 85% of non-commercial-scale biopharma manufacturing infrastructure—is the greater challenge in further growing industry acceptance of single-use technology

4. Spiders, Mold, & SOPs: Tales From A Site Inspection Veteran 5/22/2025

   Sarah Moeller, a veteran of mock regulatory inspections, shares lessons from over 300 site visits, emphasizing preparation, documentation, and patient-focused practices to ensure sites are inspection-ready.

5. What Are Smart mRNAs? 7/1/2024

   Strand Therapeutics' programmable, "smart," mRNA therapeutics could deliver precise, potentially curative treatments for solid tumors and hematological malignancies.

6. A New Year At Life Science Leader 1/1/2024

   Life Science Leader wishes you a happy New Year and announces plans for 2024.

7. Should We Be Scared Of PE Firms Investing In Sites? 12/16/2024

   It seems lately there's been a lot of vilification of private equity (PE) firms that are purchasing site networks. I'm sure this sentiment has increased during the past few years, but is it justified? 

8. A Closer Look At How RBQM Has Evolved In Recent Years 1/29/2024

   Mary Arnould, senior director, program management/RBM lead, Clinical Science Operations at Astellas, talks about her SCOPE Summit 2024 presentation called “COVID-19 Pandemic Impact on Risk-Based Quality Management.”

9. The Path To Producing An Insulin Biosimilar 7/17/2024

   I met with rBIO co-founder and president, Cameron Owen, as well as its CSO, Dr. Deenadayalan Bakthavatsalam, to learn about what it takes to develop an insulin biosimilar. They candidly told me about the company’s plan of execution, as well as how challenging it is to scale-up manufacturing to a commercial level (in the ballpark of several metric tons per year for insulin) — which is the company’s primary focus right now.

10. Biophotonics: Improving Dentistry, Diagnoses, And … Space Travel? 6/13/2024

    Biophotonics, combining biology and photonics, revolutionizes dentistry, medical diagnostics, and space travel through advanced imaging, biosensing, and therapeutic applications.